SEC Form 4 · accession 0001273902-16-000292
CIRRUS LOGIC, INC. · CRUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason P Rhode
Officer — President & CEO · Director
Period of report
Nov 10, 2016
Accepted (ET)
Nov 14, 2016 · 6:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000772406
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 10, 2016 | M | 8,211 | $23.34 | A | 155,306 | D | |
| Common StockF1 | Nov 10, 2016 | M | 6,153 | $16.25 | A | 161,459 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F2 | $16.25 | Nov 10, 2016 | M | 6,153 | D | — | Oct 6, 2020 | Common Stock | 6,153 | 0 | D |
| Incentive Stock Option (right to buy)F3 | $23.34 | Nov 10, 2016 | M | 8,211 | D | — | Oct 2, 2023 | Common Stock | 8,211 | 4,641 | D |
Explanation of responses
- F1Dr. Rhode continues to beneficially own 690,326 shares, which includes 528,867 shares issuable upon exercise of vested stock options held by Dr. Rhode and 161,459 shares held directly.
- F2The option vested on a 4-year schedule: 25% of the shares became exercisable on 10/6/2011; the remaining 75% of the shares vested at a rate of 1/36th per month over the following 36 months so that the option was fully vested and exercisable on 10/6/2014. Only vested shares can be exercised under this option.
- F3The option vests on a 4-year schedule: 25% of the shares became exercisable on 10/2/2014; the remaining 75% of the shares vest at a rate of 1/36th per month over the following 36 months so that the option will be fully vested and exercisable on 10/2/2017. Only vested shares can be exercised under this option.